CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 6,667 shares (option exercise)
- 4 Exercise or conversion Director acquired 8,333 shares (option exercise)
- 4 Exercise or conversion Director acquired 6,667 shares (option exercise)
- 4 Exercise or conversion Director acquired 6,667 shares (option exercise)
- 4 Exercise or conversion Director acquired 6,667 shares (option exercise)
- 4 Exercise or conversion President & CEO acquired 45,000 shares (option exercise)
- 4 Shares withheld for taxes Ross Leonard S gave up 2,394 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 4,175 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 40,000 shares at $1.74 ($69,600)
- 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
- 4 Open-market buy Director bought 5,000 shares at $1.89 ($9,450)
- 4 Exercise or conversion Ross Leonard S acquired 5,000 shares (option exercise)
- 4 Open-market buy President & CEO bought 28,500 shares at $1.76 ($50,246)
- 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
- 4 Open-market buy Director bought 17,000 shares at $1.75 ($29,784)
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,188 shares (to pay taxes)
- 4 Shares withheld for taxes Ross Leonard S gave up 1,735 shares (to pay taxes)
Page 14 of 23 · 459 filings